<DOC>
	<DOCNO>NCT02692157</DOCNO>
	<brief_summary>Healthy adult men abuse opioids physically dependent invite participate study examine ability NT-814 , neurokinin ( NK ) antagonist 1 3 receptor subtypes , alter abuse liability oxycodone .</brief_summary>
	<brief_title>NT-814 : Evaluation Its Ability Alter Abuse Liability Oxycodone Exploratory Clinical Study</brief_title>
	<detailed_description>After complete screen process , participant schedule admission onto General Clinical Research Unit 5-South 13-week study . During Week 1 , participant detoxify opioids . During Week 2 detoxification period , participant randomize receive one four maintenance dose NT-814 . During Weeks 3-4 participant may receive oxycodone laboratory session complete cue exposure session involve presentation neutral drug cue . Participants opportunity self-administer drug making click computer mouse . Weeks 2 , 5 , 8 , 11 medication stabilization week follow test Weeks 3-4 , 6-7 , 9-10 , 12-13 . At conclusion study , participant give exit interview study describe . Those interested treatment drug use end study offer referral study Substance Treatment Research Service treatment provider .</detailed_description>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>DSM V criterion Opioid Use Disorder moderatesevere ( 304.00 ) Physically healthy Able perform study procedure Normal body weight ( BMI &lt; 30 &gt; 17.5 ) , total body weight &gt; 50 kg ( 110 lb ) Total testosterone laboratory normal range ( 2501100 ng/dl ) Current history intranasal opioid use . Must willing use adequate form contraception ( e.g . condom combination spermicide ) duration study specify amount time participation . On parole probation Elevated liver function ( i.e . AST ALT &gt; 2 time upper limit normal ) impair renal function ( creatinine within normal limit ) 12lead ECGbased repeat demonstration QTcF &gt; 450 msec screen HIV positive Any physical disorder might make participation hazardous</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>